T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2B |
| 2 |
Sea Limited
SE
|
+$1.34B |
| 3 |
Morgan Stanley
MS
|
+$1.23B |
| 4 |
Incyte
INCY
|
+$1.05B |
| 5 |
Ross Stores
ROST
|
+$968M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.05B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.5B |
| 3 |
Visa
V
|
+$1.16B |
| 4 |
JPMorgan Chase
JPM
|
+$1.13B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.01% |
| 2 | Healthcare | 17.6% |
| 3 | Consumer Discretionary | 14.37% |
| 4 | Financials | 11.89% |
| 5 | Communication Services | 10.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
National Vision
EYE
$1.54B
| $8.14M | ﹤0.01% |
266,599
+31,408
| +13% | +$824K |
|
1327
DXC Technology
DXC
$1.79B
| $8.09M | ﹤0.01% |
489,976
-30,214
| -6% | -$481K |
|
1328
Fidelity National Financial
FNF
$12.8B
| $8.01M | ﹤0.01% |
271,737
-8,867,710
| -97% | -$244M |
|
1329
New Oriental
EDU
$8.49B
| $8.01M | ﹤0.01% |
61,487
+414
| +0.7% | +$50.4K |
|
|
SFE
1330
DELISTED
Safeguard Scientifics, Inc.
SFE
| $7.93M | ﹤0.01% |
1,132,901
+1,088
| +0.1% | +$6.88K |
|
1331
iShares Core S&P 500 ETF
IVV
$910B
| $7.75M | ﹤0.01% |
25,017
-5,441
| -18% | -$1.6M |
|
|
MGP
1332
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $7.69M | ﹤0.01% |
282,737
-137,400
| -33% | -$3.54M |
|
1333
Transmedics
TMDX
$3.11B
| $7.63M | ﹤0.01% |
426,046
-33,080
| -7% | -$517K |
|
1334
Norwegian Cruise Line
NCLH
$8.98B
| $7.63M | ﹤0.01% |
464,533
-7,119,231
| -94% | -$104M |
|
|
NEWR
1335
DELISTED
New Relic, Inc.
NEWR
| $7.63M | ﹤0.01% |
110,774
-9,580
| -8% | -$572K |
|
1336
Invesco
IVZ
$13.9B
| $7.6M | ﹤0.01% |
705,906
-59,093
| -8% | -$530K |
|
1337
Arch Capital
ACGL
$33.2B
| $7.47M | ﹤0.01% |
260,646
+2,363
| +0.9% | +$65.3K |
|
1338
Conduent
CNDT
$241M
| $7.46M | ﹤0.01% |
3,119,868
-952,481
| -23% | -$2.21M |
|
1339
Lumentum
LITE
$78B
| $7.4M | ﹤0.01% |
90,857
-3,230
| -3% | -$246K |
|
|
AGEN
1340
Agenus
AGEN
$315M
| $7.34M | ﹤0.01% |
95,201
+91,675
| +2,600% | +$5.49M |
|
1341
Roku
ROKU
$22.9B
| $7.3M | ﹤0.01% |
62,660
-4,617
| -7% | -$528K |
|
|
OPLN
1342
Openlane
OPLN
$4.34B
| $7.28M | ﹤0.01% |
529,182
+27,307
| +5% | +$375K |
|
1343
Liberty Global Class C
LBTYK
$3.46B
| $7.18M | ﹤0.01% |
334,000
-40,420
| -11% | -$807K |
|
1344
Hamilton Lane
HLNE
$5.69B
| $7.1M | ﹤0.01% |
+105,322
| New | +$6.63M |
|
1345
Valvoline
VVV
$4.25B
| $6.86M | ﹤0.01% |
354,749
-88,123
| -20% | -$1.5M |
|
1346
Culp Inc
CULP
$43.8M
| $6.81M | ﹤0.01% |
790,912
-73,248
| -8% | -$521K |
|
1347
Copa Holdings
CPA
$6.14B
| $6.75M | ﹤0.01% |
133,438
-4,996
| -4% | -$230K |
|
1348
PVH
PVH
$3.76B
| $6.75M | ﹤0.01% |
140,396
-58,078
| -29% | -$2.71M |
|
1349
iShares Core US Aggregate Bond ETF
AGG
$138B
| $6.68M | ﹤0.01% |
56,486
+6,386
| +13% | +$748K |
|
1350
Teradyne
TER
$64.2B
| $6.65M | ﹤0.01% |
78,718
-9,649
| -11% | -$647K |
|
Similar funds
T. Rowe Price Associates's Q2 2020 Portfolio in Review
As of Q2 2020, T. Rowe Price Associates held 2,591 positions worth $795B, up 26% from $632B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
T. Rowe Price Associates's Q2 2020 filing shows 79 new, 1,096 increased, 1,255 reduced and 100 closed positions. Its largest new stake was Vroom Inc: 200,362 shares worth $797M. The largest sale was Boeing, an estimated $2.05B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2020 buy was Vroom Inc: 200,362 shares worth $797M.
- T. Rowe Price Associates added most to Microsoft in Q2 2020, an estimated $2B increase.
- T. Rowe Price Associates's biggest Q2 2020 reduction was Boeing, cutting an estimated $2.05B.
- T. Rowe Price Associates fully exited Raytheon Company in Q2 2020, selling an estimated $1.01B.
- T. Rowe Price Associates's ten largest holdings make up 25% of its $795B portfolio in Q2 2020.
- T. Rowe Price Associates opened 79 new positions and closed 100 in Q2 2020.
- T. Rowe Price Associates's portfolio value rose 26% quarter-over-quarter to $795B.
Based on T. Rowe Price Associates's 13F filing for Q2 2020, filed 14 Aug 2020.